The number of short positions held in Reckitt Benckiser Group plc (OTCMKTS: RGBLY) was significantly reduced in September. On August 31, 2,489,200 shares were available for short sale, but on September 15 only 1,973,100 shares were available for short sale. That’s down 20.7% from the total number of shares available for short sale as of Aug. 31. Based on an average daily trading volume of 1,138,100 shares, the days-to-cover ratio is currently 1.7 days at the time of this writing. That’s the number she got.
The company previously declared a dividend, which was paid after it was announced on September 21. On Monday, August 8th, shareholders of record each received a dividend payment of $0.1596. This payment has been made. As a result, we get a yield of 2.45%. Shareholders did not receive a portion of this dividend on Friday 5th August as it was paid on that date.
After an intraday gain of $0.29 on Thursday, RBGLY’s share price rose to $13.56 per share. The company’s share volume was well above the average, which was 991,461 shares traded. The company traded a total of 2,329,854 shares. A leverage ratio is 0.95, a fast ratio is 0.44, a current ratio is 0.62, and a fast ratio is 0.44. Over the past year, Reckitt Benckiser Group has traded at a range of prices, with $12.94 being its all-time low and $17.90 being its all-time high. The stock price is currently $15.35 and its 50-day and 200-day simple moving averages are $15.49 and $15.35, respectively. Therefore, a share of the company can be purchased for $15.35.
Several equity analysts have recently covered RBGLY stock with their observations and opinions on the company. In a research note published on Friday, July 29, Berenberg Bank raised its target price on Reckitt Benckiser Group. The new price target is GBX 8,050 ($97.27) versus GBX 7,375 ($89.11). Reckitt Benckiser Group was upgraded from an underperform rating to a market perform rating in a research note issued by Sanford C. Bernstein on Thursday, July 28. UBS Group raised its target price on Reckitt Benckiser Group in a research note published on Thursday, July 28. The note has been published. The previous price target of 8,400 GBX ($101.50) has been raised to the new price target of 8,700 GBX ($105.12).
Finally, Barclays raised its target price on Reckitt Benckiser Group from GBX8,600 ($103.91) to GBX9,500 ($114.79) in a Research Note Ratings published on Thursday, July 28, and two professionals have recommended that share to sell. The company currently receives a Hold rating and its price target currently stands at $8,187.50, according to data from Bloomberg.com.
Reckitt Benckiser Group plc is a British company that manufactures products related to nutrition, hygiene and health. These items are bought and then resold in several countries: the United Kingdom, the United States of America, China and India. The company sells acne treatment creams, facial cleansers and cleansing pads under various brand names. These brand names include Clearasil, Dettol, Durex, Gaviscon, and Mucinex. In addition, it offers medicines for cough, congestion, multi-symptoms and sinus problems for adults and children. This retailer stocks lube, heartburn and indigestion remedies, sex toys, condoms, and lube.
